Title of article :
A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma
Author/Authors :
S. M. Tan، نويسنده , , K. A. Behranwala، نويسنده , , P. A. Trott، نويسنده , , N. A. Nasim، نويسنده , , E. Moskovic، نويسنده , , G. Brown، نويسنده , , D. M. King، نويسنده , , N. P. M. Sacks، نويسنده , , G. P. H. Gui، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2002
Abstract :
Aims: Early invasive lobular breast carcinoma (ILC) is associated with few symptoms and signs. The individual sensitivity of clinical examination, mammography, ultrasonography, cytology and core biopsy have each been reported to be of limited value. The aim of this study was to evaluate the accuracy of triple assessment in the pre-operative detection of patients identified to have ILC from their surgical pathology. Methods: Pure ILC was defined as tumours containing at least 90% lobular features. The triple assessment of 273 patients diagnosed primarily at our institution were reviewed. Results: 87.5% of women were symptomatic and 12.5% were screen detected. The mean patient age was 59 (range 30–81) years and the median tumour size was 26 (range 5–110) mm. The main mammographic abnormalities were a spiculated lesion (33.3%), an ill-defined mass (33.3%) or architectural distortion (23.5%). The sensitivities for detecting ILC of each modality were: clinical examination (76.6%), mammography (79.8%), ultrasound examination (93.9%), fine-needle aspiration cytology (FNAC) (60.5%) and core biopsy (90.8%). Combining the three modalities of clinical examination, imaging and cyto/pathology increased the pre-operative detection rate of ILC. Conclusion: Triple assessment is useful in the diagnosis of ILC. As the features of ILC may be subtle, a high index of suspicion is required to facilitate early diagnosis.
Keywords :
invasive lobular breast carcinoma , triple assessment.
Journal title :
European Journal of Surgical Oncology
Journal title :
European Journal of Surgical Oncology